[ACRX] YoY Quarter Result on 31-Mar-2012 [#Q1]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
08-May-2012
Financial Year
2012
Quarter
31-Mar-2012 [#Q1]
Profit Trend
QoQ- -10.88%
YoY- -120.51%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
Revenue 3,025 181 95 940 329 0 0 -
PBT -10,979 -10,026 -9,631 -12,762 -7,065 -3,204 -3,439 21.32%
Tax 2 806 -618 -1,285 519 -331 248 -55.18%
NP -10,981 -10,026 -9,631 -12,762 -7,065 -3,204 -3,681 19.96%
Tax Rate - - - - - - - -
Total Cost 14,006 10,207 9,726 13,702 7,394 3,204 3,681 24.92%
Ratio Analysis
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
NP Margin -363.01 -5,539.23 -10,137.89 -1,357.66 -2,147.42 0.00 0.00 -
Per Share
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
EPS -4.85 -4.57 -4.46 -6.87 -7.21 -5.97 -117.04 -41.14%
EPS Diluted -4.85 -4.51 -4.46 -6.87 -7.21 -5.97 -117.04 -41.14%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.